Dr. Paul Louis
Chief Executive OfficerA graduate of the University of Miami Miller School of Medicine, Dr. Louis is a board-trained Emergency Medicine physician with more than 30 years of clinical practice. As co-inventor and commercializer of SafetyNeb™, he demonstrated an ability to bring a specialized medical device from initial design to national distribution within six months during the COVID-19 pandemic, achieving more than 10,000 units sold in the first two quarters and adoption across 20 states. Dr. Louis provides SmartVertigo™ with a trifecta of clinical expertise, quality management, and go-to-market execution.
Trevor Meyerowitz, PT
Chief Medical OfficerWith 36 years of clinical practice and more than 15,000 successful vestibular treatments, Trevor Meyerowitz is a subject-matter authority on the diagnosis and management of vertigo. The SmartVertigo™ System emerged directly from his clinical practice, where he identified persistent diagnostic limitations and responded by engineering a platform that translates complex nystagmus patterns into actionable, canal-specific clinical data. His proprietary dataset, accumulated over thousands of treatment encounters, forms the foundation of the system’s machine-learning model and underpins its diagnostic concordance with specialist review.
Stephen Meyerowitz
Chief Technical OfficerStephen Meyerowitz is a veteran technologist with more than 32 years of experience in medical-grade hardware and software integration. Holding a B.Com Honours degree in Information Technology, he has a documented record of building and scaling globally distributed medical systems. His technical leadership is responsible for the SmartVertigo™ architecture — bridging machine-learning analytics with a user-centric clinical interface — and he oversees the product’s technical roadmap to ensure platform robustness, security, and scalability for global deployment.
Alan Keschner
Chief Financial OfficerA Mechanical Engineer with a Master’s degree in Industrial Administration, Alan Keschner brings more than 42 years of experience across high-growth startups and established corporate environments, with particular focus on mergers, acquisitions, and statutory compliance. He provides the financial stewardship and structural rigor necessary for venture-backed growth, overseeing the legal and financial frameworks that protect shareholder value while navigating the complexities of medical device commercialization.
Kowshik Balasubramanian
AI SpecialistKowshik Balasubramanian is an AI innovator holding a Master’s in Information Technology Management from Florida Atlantic University, specializing in proprietary AI solutions. At VertigoDx, Kowshik served as the driving force behind the company’s AI strategy, taking the concept from idea to reality. His work produced a proprietary system capable of identifying vestibular dysfunction from patient videos in under a minute. He is currently expanding his expertise into the insurance and energy sectors.
